| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -3.6 | -152.6 |
| EPS (diluted, $ a share) | $-0.02 | $-0.76 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
Source
Read the filing ↗
10-Q filed with the SEC, OTC: SMNR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Semnur Pharmaceuticals, Inc.: key numbers
- Share price
- $0.4700Close, Nov 13
- Market cap
- $102M
- Shares outstanding
- 217.71MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.